Trial Profile
Study of tenofovir-associated bone adverse outcomes among a US National Historical Cohort of HIV-infected veterans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2018
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Atazanavir/ritonavir; Darunavir/ritonavir; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat; Lopinavir/ritonavir; Rilpivirine; Ritonavir
- Indications HIV infections
- Focus Adverse reactions
- 16 Jul 2018 New trial record
- 01 Jun 2018 Results published in the Infectious Diseases and Therapy